A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy Participants
Clinical trial NCT06194214 · COMPLETED
Trial details
- NCT number
- NCT06194214
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-11
- Primary completion
- 2021-06-09
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.